Immix Biopharma

IMMXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$678.365 M

$9.72 -3.38%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$29.4M

Loss-making

Shares outstanding

71,539,314

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#190Zevra TherapeuticsZVRA$686.5M
#191NeurogeneNGNE$682.2M
#192Immix BiopharmaIMMX$678.4M
#193Faeth TherapeuticsFTH$630.2M
#194Crescent BiopharmaCBIO$625.5M

Where these numbers come from

Share counts and financials for Immix Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.